Back

Apabetalone (RVX-208) impacts key biomarkers and pathways associated with cardiovascular disease in patients with severe renal impairment

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - CAD and comorbidities CAD and comorbidities ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Ewelina Kulikowski

Calgary (Canada)

69 More presentations in this session

Presentation thumbnail
Professor C. Gale (Leeds, GB)
Presentation thumbnail
Professor C. Gale (Leeds, GB)
Presentation thumbnail
Doctor G. Cediel Calderon (Tarragona, ES)
Abstract
Presentation thumbnail
Miss S. BenAicha Gonzalez (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Doctor W. Su (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - CAD and comorbidities

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources